NEW

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

Mirragen Advanced Wound Matrix Gains FDA Clearance

ETS Wound Care LLC has announced that Mirragen Advanced Wound Matrix was cleared by the United States Food and Drug Administration (FDA) for treatment of acute and chronic wounds. Mirragen is a fully resorbable borate glass matrix comprised of fibers and beads proven to be highly effective in wound care management.

Mirragen is packed into wounds to manage and control wound fluids, while the resorbable matrix provides an environment for optimal wound healing.

“Anyone who is treating or experiencing discomfort from acute or chronic wounds will immediately recognize the benefits of Mirragen,” said Peggy Earl, BSN, RN, WOCN, a wound care specialist at Phelps County Regional Medical Center in Rolla, Missouri. “Mirragen has the potential to reduce the required number of episodes and duration of wound care treatment, while allowing the body to effectively heal a variety of wounds, both acute and chronic.”

ETS Wound Care plans to make Mirragen commercially available via a controlled domestic market release in early Q2 2017 and available to the broader domestic market in 2018.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X